We also observed that FOXO1-overexpressing NPC cells exhibited lower expression of CSC markers (CD133 and CD44) compared with that of the vector control cells, as shown by an immunofluorescence discrimination assay (Fig. 1c). The gene discussed is CD44; the disease is nasopharyngeal carcinoma.